By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

National Comprehensive Cancer Network 

500 Old York Road, Suite 250

Jenkintown  Pennsylvania  19046  U.S.A.
Phone: 215-690-0300 Fax: 215-690-0280


SEARCH JOBS


Industry
Services
Healthcare






Company News
Myriad Genetics, Inc. (MYGN) Release: National Comprehensive Cancer Network Updates Guidelines For Hereditary Colon Cancer Testing 3/4/2014 9:03:18 AM
Researchers Receive Grants From National Comprehensive Cancer Network Oncology Research Program Funded Through AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO)/Astellas Pharma Inc. (YPH.BE) Collaboration 10/15/2012 10:19:24 AM
National Comprehensive Cancer Network Appoints Dr. Robert Carlson as CEO 9/24/2012 7:35:24 AM
Researchers Receive Grants From National Comprehensive Cancer Network Oncology Research Program Funded Through GlaxoSmithKline (GSK) 9/6/2012 9:58:59 AM
Researchers Receive Grants From National Comprehensive Cancer Network Oncology Research Program Funded Through Boehringer Ingelheim Corporation 9/4/2012 10:38:04 AM
Highlights of the National Comprehensive Cancer Network 17th Annual Conference Include Presentations on Lung Cancer Screening, Melanoma, and Non-Hodgkin’s Lymphomas 3/29/2012 7:28:10 AM
National Comprehensive Cancer Network Presents New Guidelines for Acute Lymphoblastic Leukemia 3/21/2012 6:25:55 AM
National Comprehensive Cancer Network to Hold 17th Annual Conference: Sam Donaldson and Clifford Goodman Lead Roundtable Discussions on Critical Issues in Cancer Care 3/13/2012 6:53:27 AM
National Comprehensive Cancer Network Collaborates with AVEO Pharmaceuticals, Inc. (AVEO) and Astellas Pharma Inc. (YPH.BE) on Innovative Cancer Research 2/17/2012 6:45:06 AM
National Comprehensive Cancer Network Receives $2 Million in Oncology Research Funding from Boehringer Ingelheim Corporation to Investigate Afatinib in Solid Tumors 11/10/2011 8:38:39 AM
123456
//-->